HQH vs HTD

Tekla Healthcare Investors vs John Hancock Tax Advantaged Div — Valuation Comparison 2026

HQH

Asset Management
Tekla Healthcare Investors
Quality
1.8
out of 10
Value Trap
—
—
Price
$19.65
Last close
Models
9/13
Active
VS

HTD

Asset Management
John Hancock Tax Advantaged Div
Quality
1.7
out of 10
Value Trap
—
—
Price
$25.72
Last close
Models
10/13
Active

Model-by-Model Comparison

ModelType HQH Fair ValueHQH Upside HTD Fair ValueHTD Upside
Bayesian DCF Intrinsic $5.20 -73.5% $6.81 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $22.03 +12.1% $43.08 +66.6%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
RCMH-DCF Intrinsic $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HQH vs HTD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HQH vs HTD — Which Stock Is More Undervalued?

HQH scores higher with a 1.8/10 quality rating vs HTD's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Tekla Healthcare Investors (HQH) and John Hancock Tax Advantaged Div (HTD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HQH currently trades at $19.65 with a QOC of 1.8/10, while HTD trades at $25.72 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).

HQH
View Full Tekla Healthcare Investors Analysis →
HTD
View Full John Hancock Tax Advantaged Div Analysis →